List of PhD projects labeled by MAbImprove for 2021 in the field of antibodies. This list will be updated with application procedures as soon as available; it is susceptible to change as MAbImprove teams secure cofunding.
In Tours
Targeted vectorization of metformin to potentiate the action of chemotherapies used in triple negative breast cancers.
Supervisor : Dr. Emilie Allard-Vannier (EA6295 NMNS)
Un virus pour améliorer l’interaction sociale
Encadrant : Dr. Lucie Pellissier (UMR PRC BIOS)
Financement : ERC – MAbImprove
Plus de détails et candidature
Thérapie combinée basée sur le protozoaire oncolytique Neospora caninum armé d’anticorps thérapeutiques comme stratégie innovante pour le traitement du glioblastome.
Encadrant : Dr. Nicolas Aubrey (UMR1282 BioMAP)
Utilisation diagnostique et thérapeutique des anticorps anti- cytomégalovirus en transplantation rénale.
Encadrant : Dr. Philippe Gatault (EA4245 T2i)
Ciblage de la signalisation endosomale des récepteurs des Gonadotrophines à l’aide de VHH pH-dépendants.
Encadrant(s) : Dr. Frédéric Jean-Alphonse (UMR PRC BIOS)
A Montpellier
Sensitizing the tumor microenvironment to immune checkpoint therapy trough mAb-based therapeutic combinations in pancreatic cancer
Supervisor: Dr. Laurent Gros (IRCM)
Funding: Université de Montpellier – MAbImprove
Targeting T cell motility and recruitment in Type 1 Diabetes.
Supervisor: Dr. Javier Hernandez (IRMB)
Funding: Université de Montpellier – MAbImprove
Targeting the breast cancer tumor microenvironment with highly hydrophilic 4th generation anti-cathepsin D ADCs (Antibody-Drug Conjugates) with homogeneous DAR8
Supervisor: Dr. Thierry Chardès (IRCM)
Development and validation of an intracellular delivery system for antibody fragments
Supervisor: Dr. Pierre Martineau (IRCM)
Generation and combination of pH-dependent antibodies targeting the anti-EGFR receptor family
Supervisor: Dr. Bruno Robert (IRCM)
Comparative genomic analysis of the adaptive immune response loci of Pan troglodytes, ComPanY
Supervisor: Pr. Sofia Kossida (IMGT)
Improving Immunotherapy of Hepatocellular Carcinoma using a Novel Bifunctional Anti-PDL1/PRELP-Fusion Protein
Supervisor: Dr. Andrei Turtoi (IRCM)